Lea Eisenbach
Affiliations: | Weizmann Institute of Science, Rehovot, Israel |
Area:
Immunology, Microbiology BiologyGoogle:
"Lea Eisenbach"Children
Sign in to add trainee| Ilan Volovitz | grad student | 2006 | Weizmann Institute |
| Vered D. Carmi | grad student | 2008 | Weizmann Institute |
| Ofir Goldberger | grad student | 2008 | Weizmann Institute |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kacen A, Javitt A, Kramer MP, et al. (2022) Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors. Nature Biotechnology |
| Solomon A, Alteber Z, Bassan D, et al. (2022) On the development of a neoantigen vaccine for the prevention of Lynch Syndrome. International Journal of Cancer |
| Bassan D, Gozlan YM, Sharbi-Yunger A, et al. (2021) Avidity optimization of a MAGE-A1 specific TCR with somatic hypermutation. European Journal of Immunology |
| Wolf Y, Bartok O, Patkar S, et al. (2019) UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma. Cell |
| Bassan D, Gozlan YM, Sharbi-Yunger A, et al. (2019) Optimizing T cell receptor avidity with somatic hypermutation. International Journal of Cancer |
| Sharbi-Yunger A, Grees M, Gal C, et al. (2018) A universal anti-cancer vaccine: Chimeric invariant chain potentiates the inhibition of melanoma progression and the improvement of survival. International Journal of Cancer |
| Grees M, Sharbi-Yunger A, Evangelou C, et al. (2018) Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models. Oncoimmunology. 7: e1445457 |
| Zupančič E, Curato C, Kim JS, et al. (2018) Nanoparticulate vaccine inhibits tumor growth via improved T cell recruitment into melanoma and huHER2 breast cancer. Nanomedicine : Nanotechnology, Biology, and Medicine |
| Alteber Z, Sharbi-Yunger A, Pevsner-Fischer M, et al. (2017) The anti-inflammatory IFITM genes ameliorate colitis and partially protect from tumorigenesis by changing immunity and microbiota. Immunology and Cell Biology |
| Sharbi-Yunger A, Grees M, Tzehoval E, et al. (2016) mRNA-based dendritic cell immunization improves survival in ret transgenic mouse melanoma model. Oncoimmunology. 5: e1160183 |